Swiss Medical Weekly released a feature study entitled, “Hypoglycaemic Effect Of Artemisia Sphaerocephala Krasch Seed Polysaccharide In Alloxan-Induced Diabetic Rats”. The main goal of this study, authored by Ji Zhang, Yulong Huang, Tiande Hou and Yunpu Wang was to examine the hypoglycaemic activity of a new polysaccharide extracted from Artemisia sphaerocephala Krasch (Asteraceae) seeds in alloxan-induced diabetic rats.
The Artemisia seed polysaccharide (ASP) underwent dynamic and static light scattering techniques to determine its molecular weight with the use of Brookhaven’s BI-200SM and BI-MwA Molecular Weight Analyzer. The prepared ASP was administered orally for four weeks to alloxan-induced diabetic rats and changes in blood glucose were observed. The results from these scientific tests indicated the possible usefulness of ASP on the decrease in serum glucose and in cholesterol and triacylglycerol level in plasma for diabetes treatment.
Morbidity and mortality rate of Diabetes Mellitus (DM) significantly increased, which mobilized experts to actively seek for new pharmalogical treatments that reduced side effects and toxicity. Researchers seek for natural and non-toxic, anti-diabetic drugs using modern day scientific methods that require instruments equipped with advanced technology. Brookhaven Instruments designs, manufactures and sells quality analytical instruments to meet all the requirements needed in research, development, process and quality control. The BI-200SM and BI-MwA are among Brookhaven Instruments’ cost-effective, convenient and reliable equipment.